Rare diseases
Investigational molecules
Locations
Back to Germany212 clinical trials in Homburg, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease
GermanyA Phase III Study of Lenbelintide in Adults with Obesity or Overweight and Weight‑Related Comorbidity Without Type 2 Diabetes
GermanyPhase 3 Randomized Double‑Blind Study of Pitolisant versus Placebo for Safety and Efficacy in Adults with Idiopathic Hypersomnia
GermanyEffect of lenbelintide (AZD6234) on body weight in adults with type 2 diabetes and obesity or overweight
GermanyA study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease
GermanyA Phase 2 Study Evaluating the Safety and Efficacy of Oral NS-863 in Adults with Pulmonary Hypertension Associated with Interstitial Lung Disease
GermanySafety and efficacy of efimosfermin alfa versus placebo in adults with compensated cirrhosis (stage F4) due to MASH
GermanyGermanyStudy of efimosfermin alfa versus placebo in adults with compensated cirrhosis from metabolic dysfunction-associated steatohepatitis (MASH)
GermanyTislelizumab with drug combination in patients with PD-L1‑high metastatic non‑small cell lung cancer and high tumor burden
GermanyPhase 2 Randomized Trial of Oral NS-863 in Patients with Pulmonary Arterial Hypertension
GermanySafety Study of DIAG723 and Sodium Chloride in Adults with Hereditary Hemorrhagic Telangiectasia
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on lymphoma and leukemia treatments, including studies evaluating novel therapies for chronic lymphocytic leukemia and various types of B-cell lymphomas.
Multiple trials exploring CAR-T cell therapies and targeted treatment combinations.
Comprehensive studies investigating treatments for various types of breast cancer, particularly focusing on hormone receptor-positive and HER2-positive disease.
Evaluating new combination therapies and targeted treatments for improved patient outcomes.
Studies addressing heart failure prevention and treatment, with innovative approaches to reducing cardiovascular risks.
Testing novel drug combinations to improve cardiovascular outcomes and patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
